PL2016940T3 - Sposoby wytwarzania i zastosowanie kompozycji kompleksów chelatowych pirofosforanu (V) i cytrynianu z jonami żelaza (III) - Google Patents

Sposoby wytwarzania i zastosowanie kompozycji kompleksów chelatowych pirofosforanu (V) i cytrynianu z jonami żelaza (III)

Info

Publication number
PL2016940T3
PL2016940T3 PL08159949T PL08159949T PL2016940T3 PL 2016940 T3 PL2016940 T3 PL 2016940T3 PL 08159949 T PL08159949 T PL 08159949T PL 08159949 T PL08159949 T PL 08159949T PL 2016940 T3 PL2016940 T3 PL 2016940T3
Authority
PL
Poland
Prior art keywords
ferric
preparation
methods
ferric pyrophosphate
citrate chelate
Prior art date
Application number
PL08159949T
Other languages
English (en)
Inventor
Jr William S Mccall
Original Assignee
Rockwell Medical Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockwell Medical Tech Inc filed Critical Rockwell Medical Tech Inc
Publication of PL2016940T3 publication Critical patent/PL2016940T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
PL08159949T 2007-07-20 2008-07-08 Sposoby wytwarzania i zastosowanie kompozycji kompleksów chelatowych pirofosforanu (V) i cytrynianu z jonami żelaza (III) PL2016940T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96132707P 2007-07-20 2007-07-20
US12/138,018 US7816404B2 (en) 2007-07-20 2008-06-12 Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
EP08159949A EP2016940B1 (en) 2007-07-20 2008-07-08 Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions

Publications (1)

Publication Number Publication Date
PL2016940T3 true PL2016940T3 (pl) 2012-09-28

Family

ID=40019183

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08159949T PL2016940T3 (pl) 2007-07-20 2008-07-08 Sposoby wytwarzania i zastosowanie kompozycji kompleksów chelatowych pirofosforanu (V) i cytrynianu z jonami żelaza (III)

Country Status (11)

Country Link
US (1) US7816404B2 (pl)
EP (1) EP2016940B1 (pl)
JP (1) JP5489196B2 (pl)
AT (1) ATE554754T1 (pl)
CY (1) CY1113903T1 (pl)
DK (1) DK2016940T3 (pl)
ES (1) ES2383713T3 (pl)
HR (1) HRP20120416T1 (pl)
PL (1) PL2016940T3 (pl)
PT (1) PT2016940E (pl)
SI (1) SI2016940T1 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090124572A1 (en) * 2007-11-09 2009-05-14 Deanna Jean Nelson Iron-containing nutritional supplement
AU2009262967C1 (en) 2008-06-25 2015-12-24 Fe3 Medical, Inc Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
WO2010034359A1 (en) * 2008-09-29 2010-04-01 Vifor (International) Ag Receptacle and method for storing and supplying a liquid and a liquid medical preparation
US8348922B2 (en) * 2009-02-12 2013-01-08 Incube Labs, Llc Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent
US9008765B2 (en) 2009-02-12 2015-04-14 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US8190252B2 (en) * 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
WO2010151845A2 (en) * 2009-06-26 2010-12-29 Incube Labs, Llc Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use
US8178709B2 (en) * 2009-07-21 2012-05-15 Biolink Life Sciences, Inc. Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
WO2011044175A2 (en) 2009-10-06 2011-04-14 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
WO2011100376A2 (en) 2010-02-10 2011-08-18 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
EP2497380A1 (en) * 2011-03-10 2012-09-12 DSM IP Assets B.V. Process for iron supplementation of beverages
AU2012230701B2 (en) 2011-03-24 2016-09-29 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents
RU2472500C1 (ru) * 2012-05-05 2013-01-20 Илья Николаевич Медведев Способ нормализации активности антитромбина iii в крови у новорожденных телят с железодефицитной анемией
US20150320091A1 (en) * 2012-05-08 2015-11-12 Dsm Ip Assets B.V. Iron supplementation of rice kernels
JP2016507527A (ja) 2013-02-01 2016-03-10 チャラク エルエルシー 可溶性ピロリン酸第二鉄を用いて鉄欠乏症を治療する方法
EP3038475B1 (en) * 2013-08-28 2018-06-27 DSM IP Assets B.V. Iron supplementation of a bouillon concentrate
WO2015069656A1 (en) 2013-11-05 2015-05-14 Rockwell Medical, Inc. Methods of reducing doses of erythropoietin stimulating agents in hyporesponsive patients
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
JP5963185B1 (ja) * 2015-04-13 2016-08-03 富田製薬株式会社 ピロリン酸第二鉄含有粉末及びその製造方法
EP3284717B1 (en) * 2015-04-13 2019-10-30 Tomita Pharmaceutical Co., Ltd. Powder containing ferric pyrophosphate and method for producing same
WO2017040937A1 (en) * 2015-09-04 2017-03-09 Rockwell Medical, Inc. Solid soluble ferric pyrophosphate formulations, kits, and methods using the same
EP3153162A1 (en) 2015-10-05 2017-04-12 Navinta, llc. Preparation of pharmaceutical dosage forms containing iron (iii) salts
CN108883085A (zh) 2016-01-06 2018-11-23 罗克韦尔医疗公司 用铁化合物和柠檬酸盐化合物的组合物疗法
CN106977552B (zh) * 2016-01-19 2019-11-05 山东诚创医药技术开发有限公司 枸橼酸焦磷酸铁混配络合物的制备方法
JP6887598B2 (ja) * 2016-07-21 2021-06-16 富田製薬株式会社 鉄含有飲食品
CN106619494A (zh) * 2016-10-10 2017-05-10 泰州海达医药科技有限公司 枸橼酸焦磷酸铁溶液及其制备方法
MX2019011725A (es) 2017-03-31 2020-07-28 Abbott Lab Composiciones nutricionales liquidas que contienen aceite de pescado oxidable, acido rosmarinico y hierro ferrico.
EP3778868B1 (de) 2019-08-16 2022-01-26 UGA Biopharma GmbH Zellkulturmedium zur kultivierung von zellen, verfahren zum kultivieren von zellen und verfahren zur expression von mindestens einem rekombinanten protein in einer zellkultur
CN112159434A (zh) * 2020-09-23 2021-01-01 北京沣瑞医药科技有限公司 枸橼酸焦磷酸铁配合物的制备方法
CA3191492A1 (en) * 2020-09-29 2022-04-07 LG Bionano, LLC Methods of preparing iron complexes
CN112516163A (zh) * 2020-12-21 2021-03-19 西安医学院 一种难溶性三价铁纳米脂质体复合物及其制备方法
WO2026017901A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in neurodevelopmental or psychiatric disorder

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE579299A (pl) * 1958-06-04
US3275514A (en) * 1960-04-12 1966-09-27 Paul D Saltman Process for introduction of metals into the mammalian system
US3259500A (en) * 1961-10-11 1966-07-05 Kentucky Res Foundation Method for inhibiting anemia in young pigs by feeding the sow an iron agent
US3367834A (en) * 1965-05-04 1968-02-06 Dexter Martin Method and compositions for enhancing the utilization of iron by mammals
AT279048B (de) * 1967-07-04 1970-02-25 Pharmazeutische Fabrik Montavit Gmbh Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon
US3686397A (en) * 1970-05-18 1972-08-22 Mueller Arthur Parenteral iron preparations
SE359447B (pl) * 1971-10-06 1973-09-03 Astra Laekemedel Ab
US4167564A (en) * 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
US4058621A (en) * 1975-02-24 1977-11-15 Peter, Strong & Company, Inc. Iron complexes and foodstuffs containing them
JPS5626709A (en) * 1979-08-04 1981-03-14 Nichia Kagaku Kogyo Kk Manufacture of water soluble iron salt
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8713169D0 (en) * 1987-06-05 1987-07-08 Peters T J Uptake of iron by body
CO4410161A1 (es) 1994-02-28 1997-01-09 Kellog Co Producto de cereal listo para comer fortificado con complejo de edta ferrico y metodo para producirlo
DE69734781T2 (de) * 1996-12-31 2006-07-20 Gupta, Ajay, Cerritos Verfahren und pharmazeutische zusammensetzung zum zuführen von eisen bei hämodialyse-und peritonealdialysepatienten
WO2001000204A1 (en) 1999-06-30 2001-01-04 Ajay Gupta Method and pharmaceutical composition for parenteral administration of iron
US20030190355A1 (en) 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
TWI335218B (en) * 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US20060134227A1 (en) 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
PT1973552T (pt) * 2005-12-23 2017-07-18 Gupta Ajay Composição para nutrição parenteral contendo ferro

Also Published As

Publication number Publication date
SI2016940T1 (sl) 2012-07-31
HRP20120416T1 (hr) 2012-07-31
ES2383713T3 (es) 2012-06-25
US7816404B2 (en) 2010-10-19
JP5489196B2 (ja) 2014-05-14
EP2016940B1 (en) 2012-04-25
JP2009108027A (ja) 2009-05-21
US20090023686A1 (en) 2009-01-22
DK2016940T3 (da) 2012-06-18
ATE554754T1 (de) 2012-05-15
CY1113903T1 (el) 2016-07-27
PT2016940E (pt) 2012-07-12
EP2016940A1 (en) 2009-01-21

Similar Documents

Publication Publication Date Title
PL2016940T3 (pl) Sposoby wytwarzania i zastosowanie kompozycji kompleksów chelatowych pirofosforanu (V) i cytrynianu z jonami żelaza (III)
NZ580226A (en) Dimer compounds as inhibitors of iap
PH12015500891B1 (en) A stable iron oligosaccharide compound
MX2010013682A (es) Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos.
MY199552A (en) Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preapring the same
PL1951729T3 (pl) Pochodne pirymidyny połączone przez atom tlenu
BRPI0820299A2 (pt) Composições bucais estanosas
UA105018C2 (uk) Акриламідопохідні, застосовні як інгібітори переходу мітохондріальної проникності
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
MY159197A (en) Anticancer derivatives, preparation thereof and therapeutic use thereof
MX2010014230A (es) Composiciones que contienen pirido [2,3-d] pirimidinas sustituidas con metilmorfolina y proceso relacionado.
WO2009121935A3 (en) Pharmaceutical composition with bisphosphonate
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
MX343326B (es) Metodos para mejorar el metabolismo energetico.
EP2131849A4 (en) COMPOSITIONS AND METHODS OF DISTRIBUTING AGENTS AGAINST CANCER
MX2010005867A (es) Polimorfos de un inhibidor de c-met/hgfr.
TW200603746A (en) Iron sulfate based phosphate adsorbent
ATE526025T1 (de) Behandlung metastasierter tumore
WO2021034800A3 (en) Iron complexes and uses therefor
MY160005A (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
NZ584037A (en) Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same
TW200626566A (en) 4, 7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses
PH12017500636A1 (en) Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
WO2010045551A8 (en) Xanthenone-4-acetic acid derivatives
WO2010015586A3 (en) 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds